infohep news

• Some people remain at risk for liver cancer after being cured of hepatitis C

  Liz Highleyman / 22 November 2022

  People who are cured of hepatitis C with direct-acting antiviral (DAA) therapy have a much lower risk for liver cancer. The likelihood of developing liver cancer after successful treatment declines over time, but ...

• Severe acute hepatitis in children still does not have a definitive cause

  Liz Highleyman / 22 November 2022

  Clusters of unexplained acute hepatitis among children have declined from their peak in early summer, but a small number of cases are still being reported, and a singular definitive cause still has not ...

• Hepatitis C elimination

  Only 11 countries on target to eliminate hepatitis C by 2030

  Keith Alcorn / 15 November 2022

  Only 11 countries are on course to meet their goals for elimination of hepatitis C by 2030, while five countries with the highest burdens of hepatitis C are unlikely to achieve elimination ...

• Treatment for people who use drugs

  UK community test-and-treat service achieves high hepatitis C cure rate in people who use drugs

  Keith Alcorn / 15 November 2022

  Offering hepatitis C testing and treatment through a community drugs and alcohol service led to high uptake of testing and treatment among current and former injecting drug users, as well as a ...

• Mother to child

  Simplified tenofovir regimen as effective as recommended preventive treatment in pregnant women with hepatitis B

  Keith Alcorn / 14 November 2022

  A simplified regimen for the prevention of mother-to-child transmission of hepatitis B was just as effective as the standard preventive regimen in pregnant women with very high virus levels and is likely ...